Instant Market Insights

McIlvaine is conducting video conferences to answer urgent questions facing suppliers and investors.  Bob McIlvaine acts as host and can bring over 50 years of experience in the air, water, energy and contamination control industries to bear.  Since McIlvaine has very comprehensive services on Coronavirus Pharmaceutical and Technology Solutions he can offer unique insights on the impact of the virus on markets.

Discussions are enhanced with instant display of markets, market shares and technology analysis for dozens of products. The McIlvaine scope has been international since its first exhibition in London Olympia at Filtration and Separation 1975. 

More Information             Video Demonstration             

Robert McIlvaine Biography

Consulting Services available from Robert McIlvaine

We live in a silo world where the insights we need for a decision are inaccessible. 

In McIlvaine’s Instant Market Answers program discussions are conducted by Bob McIlvaine as on line video conferences.  Revenue forecasts for many flow and treat applications in different countries and industries can be displayed. McIlvaine has 15 reports with an average of 50,000 forecasts per report which are current and can be instantly accessed on line.

Market share data on thousands of companies is on display as well as lots of project data. The client may not need to know the details but if they can see a display of gas turbine installations in Algeria, coal fired power plants in India or the cleanrooms in California it will provide an instant insight.

Much time has been spent in the last six months analyzing the coronavirus impacts on the flow and treat industry. There are major negative impacts for most flow and treat companies but for suppliers of air filters and masks it is an unprecedented opportunity. McIlvaine has services with daily alerts on both the technology and pharmaceutical solutions. This provides perspective on the longer term impact by country and product.

Bob McIlvaine is available for conferences as short as 30 minutes or for extended engagements. There is much to contribute relative to sales or product decisions. Another great value can be advice for senior management relative to organic  growth or acquisitions.

Bob was in the flow and treat industry from 1958 to 1974 when he started the McIlvaine Company. In the last 46 years he has been involved in many of the company’s publications as well as consulting projects.  This includes acquisition advice. The first assignment was with Brown Boveri to evaluate Asea prior to the merger and launch of ABB.  He have represented buyers, sellers, or bidders in over 30 assignments.  He has been an expert witness in lawsuits where the size of the market or ease of entry was in dispute.  Consulting assignments have been conducted for many of the world’s largest companies.

For Cardinal Health he led a team in an assignment to compare reusable vs surgical gowns. They needed to create a common metric to measure all harm and good. This metric was well received and has been featured in hospital magazines.  It is equally applicable to evaluating any flow and treat product.

83AI  Pharma Prospects   $1,600.00/year ($90.00/year each additional user)  Click Here to Order

Weekly Alerts, 5 year forecasts for each country and an Intelligence System provide suppliers of air, water, and process equipment and consumables with a program to pursue pharmaceutical and biotechnology opportunities on a worldwide basis. The basic data is just the first step in an Industrial Internet of Wisdom approach which will result in collaboration and the ability to “pull” in customers rather than “push” them to an order.

Sample Profile       Weekly Alert Sample       Search Pharma Prospects Website        Video Demonstration

Forecasts

Subscribers receive periodic excel spreadsheets with 5 year forecasts of pharmaceutical production revenues as well as flow and treat revenues in each country

The market for pharmaceutical air and water flow and treat products and services will grow to $55 billion in 2025

2020 was an unusual year with big growth in vaccines but slowdown in many pharmaceutical projects. However, the industry is returning to normal, and the market has been strong in the first half of 2021.  The pandemic surge in India and other countries without vaccines is likely to result in continued expansion of vaccination production for the next several years.

Certain segments of the market will grow more rapidly than others. Cell and gene therapy projects are a small portion of the total. But this segment is growing three times faster than the average.

The top ten purchasing countries in 2025 will account for 90% of the market.

The air and water flow and treat expenditures will equal 3.9% of the pharmaceutical revenues in 2025.. the volumes of air and water being treated are modest compared to the chemical or mining industry.  On the other hand, the potency and sensitivity of the products result in very high investments per unit of fluid moved or treated. This ratio is at its highest in cell and gene therapy.  This potency and sensitivity have also resulted in single use systems which are converting one time into continual equipment investments.

Here is a segmentation of the purchases by product.  The categories include associated flow control instruments, software and hardware.  Service and repair parts are also included.

Project Tracking Overview

Weekly Alerts and an Intelligence System provide suppliers of air, water, and process equipment and consumables with a program to pursue pharmaceutical and biotechnology opportunities on a worldwide basis.  The basic data is just the first step in an Industrial Internet of Wisdom approach which  will result in collaboration and the ability to “pull” in customers rather than “push” them to an order.

The ability to search Alerts back several years results in comprehensive knowledge about the following key aspects.

The service reports on water, air, and process activities and provides the opportunity for collaboration with suppliers of complementary equipment and services. It is part of an Industrial Internet of Wisdom.

The equipment and chemicals used in processing are often required to achieve higher performance than that used in air and water applications. Pumps and valves with both the ability to remain clean while moving slurries are needed. Due to the specific needs for cell and gene therapy single use products are now in demand.

Bob McIlvaine can answer your questions at 847 226 2391 or This email address is being protected from spambots. You need JavaScript enabled to view it.

Pharmaceutical Industry Candidates for Direct Sales Programs

Consolidation and international expansion are resulting in the concentration of decision making about cleanroom consumables. The top 25 pharmaceutical companies will purchase 45 percent of cleanroom consumables in 2020. The top three will purchase more than 10 percent of the total. The top 100 pharmaceutical manufacturers will make 70 percent of the purchases.

For more information on this program contact Bob McIlvaine at rmcilvaine@mcilvaine company.com 847 784 0012 ext. 112